Can self-monitoring blood glucose control decrease glycated hemoglobin levels in diabetes mellitus

Endocrinologist

Volumn 12, Issue 4, 2002, Pages 349-356

  Özmen, Bilgin ^a   Boyvada, Sibel ^a  

^a NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0036072906     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200207000-00012     Document Type: Article

References (45)

1. Totally reimbursed care for type 2 diabetes in 1994: Characteristics and follow-up
2. Current trends and new approaches in the management of diabetes mellitus
3. The increasing prevalence of diabetes and its economic burden
4. Therapeutic objectives and their practical achievement in type 2 diabetes
5. Intensive or conventional insulin therapy in type 2 diabetic patients? A population-based study on metabolic control and quality of life (The JEVIN-trial)
6. Is there a glycemic threshold for mortality risk?
7. Hyperglycemia as a risk factor for cardiovascular disease in type diabetes
8. HbA1C measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
10. Family and disease management in young type 1 diabetic patients
11. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
13. Recent progress in HbA1c testing
14. Postprandial blood glucose
15. The target for good glycemic control should be an HbA1c concentration of less than 0.07
16. Self-monitoring of blood glucose. Improvement of diabetic control
17. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose
18. Glucose monitoring in type 2 diabetes
19. Improved glycemic control in intensively treated type 1 diabetic patients using blood glucose meters with storage capability and computer-assisted analyses
20. Standards of medical care for patients with diabetes mellitus. Position statement
21. Frequency of blood glucose monitoring in relation to glycemic control
22. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
23. HbA1c does not reflect prandial plasma glucose excursions in type 2 diabetes
24. Glycemic control in diabetes mellitus
25. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry
26. Implications of the diabetes control and complications trial
27. Good continuity of care may improve quality of life in type 2 diabetes
28. Quality specifications derived from objective analyses based upon clinical needs
29. Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital
30. Effect of home blood glucose monitoring on the management of patients with NIDDM in the primary care setting
31. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes
32. Self-monitoring in type 2 diabetes mellitus: A meta-analysis
33. Diabetes self-management education
34. Pakistani Moslems with type 2 diabetes mellitus: Effect of sex, literacy skills, known diabetic complications and place of care on diabetic knowledge, reported self-monitoring management and glycemic control
35. Effects of peer-group intervention on metabolic control of adolescents with IDDM
36. Continuous subcutaneous insulin infusion
37. Self-regulation in the treatment of type II diabetes
38. A comparison of learning activity packages and classroom instruction for diet management of patients with non-insulin dependent diabetes mellitus
39. Effectiveness of selfmanagement training in type 2 diabetes
40. The cardiovascular risk associated with impaired glucose tolerance
41. Hyperglycemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study
42. Postprandial glucose and vascular disease
43. The postprandial state and risk of cardiovascular disease
44. Acute hyperglycemia and oxidative stress generation
45. α-glucosidase inhibitors as agents in the treatment of diabetes